FDA Recalls · October 8, 2026 · Primary source
Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter
Summary
Par Health issued a voluntary nationwide recall of two specific lots of Brevital Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to the hospital level due to the presence of particulate matter identified as cellulose. The recall was announced October 8, 2026, and applies to hospitals that received the affected lots. Methohexital is a Schedule IV controlled substance used as an intravenous anesthetic.
What this may mean
Hospitals that received the two affected lots of Brevital Sodium must quarantine and return those units. The recall does not establish new regulatory obligations but creates an immediate supply-chain disruption for facilities using methohexital as an anesthetic agent.
Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.
Related items
- FDA Recalls · August 20, 2026Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin LevelsScore 68
- FDA Recalls · August 24, 2026Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super PotencyScore 50
- FDA Recalls · October 7, 2026Nova Biomedical® Announces Global Medical Device Correction for StatStrip® Glucose Hospital MeterScore 48
- FDA Recalls · August 28, 2026B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate MatterScore 48
- FDA Recalls · September 4, 2026American Regent, Inc. Issues Voluntary Nationwide Recall of Three Lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) Due to the Presence of Particulate Matter and Lack of Assurance of SterilityScore 46
- FDA Recalls · August 25, 2026Baxter Issues Voluntary Nationwide Recall for One Lot of 70% Dextrose Injection Due to Potential Presence of Particulate MatterScore 43